Advanced Drainage Systems (WMS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Net sales for Q3 FY25 rose 4.3% year-over-year to $690.5M–$691M, driven by strong residential, non-residential, and infrastructure demand, with Infiltrator segment growth aided by the Orenco acquisition.
Net income declined 23% to $82.3M, and adjusted EBITDA decreased 6.2% to $191.5M, with margin at 27.7% versus 30.8% prior year.
Fifth consecutive quarter of volume growth in domestic construction markets, with notable strength in the South and Southeast.
Orenco acquisition closed in Q3, expanding advanced wastewater treatment offerings and contributing $25M in sales.
Construction market demand and material costs aligned with expectations; stormwater infrastructure concerns are rising.
Financial highlights
Q3 gross profit fell 7% to $241.6M, mainly due to unfavorable pricing, material costs, and Orenco mix; SG&A expenses rose 10.4% to $100.8M.
Free cash flow for the nine months was $373.9M, down from $563.9M prior year; year-to-date capital spending increased 22% to $166M.
Net debt to adjusted EBITDA leverage at 1.0x, with $489M cash and $590M available under the revolver.
$416M reinvested in the business and $107M returned to shareholders in the first nine months.
Interest expense increased to $23.1M in Q3, up $0.8M year-over-year.
Outlook and guidance
Fiscal 2025 net sales expected between $2.9B and $2.975B; Adjusted EBITDA forecasted at $880M–$920M.
Fourth quarter expected to be flat year-over-year, with stable pricing and material costs; margin expansion in Q4 expected from SG&A favorability and operational efficiencies.
Capital expenditures projected at approximately $225M for the year.
Guidance range reflects weather-related demand variability and integration risks.
Latest events from Advanced Drainage Systems
- Q1 sales up 4.8% to $815M; margin strong at 33.8%, but net income down 6.7%.WMS
Q1 20259 Jul 2026 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 20258 Jul 2026 - Flat Q2 sales, resilient margins, profit down; FY25 outlook reflects Orenco acquisition, cost pressures.WMS
Q2 20258 Jul 2026 - Targeting >8% organic CAGR and >$1.2B EBITDA by FY30 through innovation and disciplined capital deployment.WMS
Investor Day 202619 Jun 2026 - Strong financial results, performance-based executive pay, and enhanced ESG initiatives highlighted.WMS
Proxy filing3 Jun 2026 - Votes will be held on directors, auditor ratification, and executive compensation.WMS
Proxy filing3 Jun 2026 - Strong FY26 growth from acquisitions and product mix; FY27 outlook sees sales up but margins tighter.WMS
Q4 202621 May 2026 - Q3 profit and margin rose, NDS acquired, and $1B buyback announced amid strong cash flow.WMS
Q3 20265 Feb 2026 - Record profitability, strong ESG progress, and performance-based executive pay define FY2024.WMS
Proxy Filing1 Dec 2025